IBT is performing the ongoing Connection Study as the final part of the drug development program for IBP-9414 as a preventive treatment for NEC and to improve feeding tolerance in premature infants. Prof. Josef Neu at University of Florida in Gainesville is the coordinating investigator for this pan-US and pan-Europe and Israel drug documentation trial. NICUs participating in the Connection Study are right now recruiting premature babies in the United States and in Europe.


Your NICU would probably be a great addition to this important and pathfinding collaboration. Would you like to consider joining the study?


Here is a summary.

Would you like to consider joining the study? 


Please contactinfo@ibtherapeutics.com